Protease, Amylase, and Secretory Phospholipase A2 Levels in Human Amniotic Fluid of Fetuses with Open Spina Bifida
Fetal Diagnosis and Therapy · 15.10.2026 · 1-1
DOI: 10.1159/fdt/acuag015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fetal Diagnosis and Therapy, online erschienen am 15.10.2026. Verfasst von Tess van Schoor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Keck School of Medicine, Los Angeles, USA. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Introduction
We previously demonstrated elevated levels of secretory phospholipase A2 (sPLA2) and amylase in the amniotic fluid (AF) of a fetal rat retinoic acid (RA)-induced open spina bifida (OSB) model. Our objective was to determine whether these enzymes, as well as protease, were elevated in the AF of human fetuses with OSB.
Methods
AF was collected at the time of diagnosis (early 21–22 weeks, n = 9) or during fetoscopic repair (late 26–27 weeks, n = 12). Controls (21–22 weeks, n = 3) were amniocentesis samples collected from advanced maternal age. Activity levels of amylase, protease, and sPLA2 in these samples were measured, and we compared enzymatic activity in the control versus early groups and the early versus late groups.
Results
In comparison to the control group, the activities of amylase (p = 0.003), sPLA2 (p = 0.014), and protease (p = 0.012) were increased in the early OSB samples. No significant differences were seen in the activities of these enzymes between the early OSB and late OSB groups.
Conclusion
Protease, amylase, and sPLA2 activity were increased in the AF of human OSB fetuses but did not appear to increase further during the late second trimester. These neurotoxic enzymes may contribute to the “second hit” of OSB, the timing of which appears to be during the first half of the pregnancy. It is important to note that the assays used measure enzyme activity rather than absolute enzyme concentration, and findings should be interpreted accordingly. These findings, particularly the elevation of sPLA2, amylase, and protease activity in early second-trimester OSB samples relative to controls, are consistent with prior observations in the RA-induced rat model of OSB (J Matern Fetal Neonatal Med. 2015;29[18]:3003–3008 and J Matern Fetal Neonatal Med. 2022;35[1]:147–154). This concordance between human and animal data lends support to the continued use of the RA rat model for investigating the enzymatic contributions to the “second hit” of neural injury in OSB. Direct extrapolation should be made cautiously given differences in study design and species-specific developmental timing (see Discussion).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Keck School of Medicine, Los Angeles, USA.
- Maternal-Fetal Medicine Division, Department of Obstetrics and Gynecology, Keck School of Medicine, Los Angeles, USA.
- SC CTSI, Los Angeles, USA.
- Los Angeles Fetal Surgery, Los Angeles, USA.
- Maternal-Fetal Medicine Division, Department of Obstetrics and Gynecology, Keck School of Medicine, Los Angeles, USA, brendan.grubbs@med.usc.edu.
Zitieren
APA
van Schoor, T., Thornton, M. E., Rodman, J., Llanes, A. S., Chmait, R. H., & Grubbs, B. H. (2026). Protease, Amylase, and Secretory Phospholipase A2 Levels in Human Amniotic Fluid of Fetuses with Open Spina Bifida. Fetal Diagnosis and Therapy, 1-1. https://doi.org/10.1159/fdt/acuag015
Vancouver
van Schoor T, Thornton ME, Rodman J, Llanes AS, Chmait RH, Grubbs BH. Protease, Amylase, and Secretory Phospholipase A2 Levels in Human Amniotic Fluid of Fetuses with Open Spina Bifida. Fetal Diagnosis and Therapy. 2026:1-1. doi:10.1159/fdt/acuag015
BibTeX
@article{vanSchoor2026,
author = {van Schoor, Tess and Thornton, Matthew E and Rodman, John and Llanes, Arlyn S and Chmait, Ramen H and Grubbs, Brendan H},
title = {Protease, Amylase, and Secretory Phospholipase A2 Levels in Human Amniotic Fluid of Fetuses with Open Spina Bifida},
journal = {Fetal Diagnosis and Therapy},
year = {2026},
pages = {1--1},
doi = {10.1159/fdt/acuag015}
}
EUVIMED